Please Wait
Applying Filters...
Menu
Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 3PEMIGATINIB

02 1TAFASITAMAB

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

Brand Name : PEMAZYRE

2024 ACI Convention
Not Confirmed
arrow

Brand Name : PEMAZYRE

arrow
2024 ACI Convention
Not Confirmed

Incyte Corporation

Dosage Form : TABLET

Dosage Strength : 4.5MG

Packaging :

Brand Name : PEMAZYRE

Approval Date :

Application Number : 2519933

Regulatory Info : Prescription

Registration Country : Canada

blank

02

Brand Name : PEMAZYRE

2024 ACI Convention
Not Confirmed
arrow

Brand Name : PEMAZYRE

arrow
2024 ACI Convention
Not Confirmed

Incyte Corporation

Dosage Form : TABLET

Dosage Strength : 9MG

Packaging :

Brand Name : PEMAZYRE

Approval Date :

Application Number : 2519941

Regulatory Info : Prescription

Registration Country : Canada

blank

03

Brand Name : PEMAZYRE

2024 ACI Convention
Not Confirmed
arrow

Brand Name : PEMAZYRE

arrow
2024 ACI Convention
Not Confirmed

Incyte Corporation

Dosage Form : TABLET

Dosage Strength : 13.5MG

Packaging :

Brand Name : PEMAZYRE

Approval Date :

Application Number : 2519968

Regulatory Info : Prescription

Registration Country : Canada

blank

04

Brand Name : MINJUVI

2024 ACI Convention
Not Confirmed
arrow

Brand Name : MINJUVI

arrow
2024 ACI Convention
Not Confirmed

Incyte Corporation

Dosage Form : POWDER FOR SOLUTION

Dosage Strength : 200MG/VIAL

Packaging :

Brand Name : MINJUVI

Approval Date :

Application Number : 2518627

Regulatory Info : Prescription

Registration Country : Canada

blank